As of November 6, 2026, 8 holders' latest Schedule 13D or 13G filings report owning 5% or more of Park Ha Biological Technology Co., Ltd. The largest reported stake is Corin Global Partners Holdings Limited's, at 9.8%. 8 filings are on record since August 10, 2026 (Schedule 13G, August 10, 2026).
Who owns Park Ha Biological Technology Co., Ltd.?
Sell to companies like Park Ha Biological Technology Co., Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Motovance Holdings Limited · Sole voting: 422,500 · Shared voting: 0 · Sole dispositive: 422,500 · Shared dispositive: 0 · SCHEDULE 13G, 2026-08-13
- · Reporting person: Corin Global Partners Holdings Limited · Sole voting: 422,500 · Shared voting: 0 · Sole dispositive: 422,500 · Shared dispositive: 0 · SCHEDULE 13G, 2026-08-10
- · Reporting person: Peverel Summit Holdings Limited · Sole voting: 422,500 · Shared voting: 0 · Sole dispositive: 422,500 · Shared dispositive: 0 · SCHEDULE 13G, 2026-08-10
- · Reporting person: Rove Trading Co., Limited · Sole voting: 422,500 · Shared voting: 0 · Sole dispositive: 422,500 · Shared dispositive: 0 · SCHEDULE 13G, 2026-08-10
- · Reporting person: Velociti Group Limited · Sole voting: 422,500 · Shared voting: 0 · Sole dispositive: 422,500 · Shared dispositive: 0 · SCHEDULE 13G, 2026-08-10
Park Ha Biological Technology Co., Ltd. has 8 Schedule 13D or 13G filings on record since 2026-08-10. 8 holders' latest filing reports 5% or more of class a ordinary shares, par value $0.008 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Corin Global Partners Holdings Limited | 9.8% | 422,500 | SCHEDULE 13G, 2026-08-10 | 2026-08-03 |
| Peverel Summit Holdings Limited | 9.8% | 422,500 | SCHEDULE 13G, 2026-08-10 | 2026-08-03 |
| Rove Trading Co., Limited | 9.8% | 422,500 | SCHEDULE 13G, 2026-08-10 | 2026-08-03 |
| Velociti Group Limited | 9.8% | 422,500 | SCHEDULE 13G, 2026-08-10 | 2026-08-03 |
| Fusen Advertising Design Limited | 9.8% | 422,500 | SCHEDULE 13G, 2026-08-10 | 2026-08-03 |
| Motovance Holdings Limited | 9.7% | 422,500 | SCHEDULE 13G, 2026-08-13 | 2026-08-03 |
| Nexera Technology Company Limited | 9.1% | 390,000 | SCHEDULE 13G, 2026-08-10 | 2026-08-03 |
| Pinnacle International Holding Limited | 7.6% | 325,000 | SCHEDULE 13G, 2026-08-10 | 2026-08-03 |
Holding shares or following this stake? See who's behind Park Ha Biological Technology Co., Ltd. and the warning signs.
Free to see. No signup.
Keep reading
More on Park Ha Biological Technology Co., Ltd. and the records around it.
Park Ha Biological Technology Co., Ltd. elsewhere on the record
- IPO filing Jan 2026
- Who owns it
Watch Park Ha Biological Technology Co., Ltd.
Get an email when Park Ha Biological Technology Co., Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Park Ha Biological Technology Co., Ltd.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Park Ha Biological Technology Co., Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Park Ha Biological Technology Co., Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
20 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Corin Global Partners Holdings Limited | 422,500 | 0 | 422,500 | 0 | SCHEDULE 13G, 2026-08-10 |
| Ng Yee Loon | 422,500 | 0 | 422,500 | 0 | SCHEDULE 13G, 2026-08-10 |
| Peverel Summit Holdings Limited | 422,500 | 0 | 422,500 | 0 | SCHEDULE 13G, 2026-08-10 |
| Qi Meng | 422,500 | 0 | 422,500 | 0 | SCHEDULE 13G, 2026-08-10 |
| Rove Trading Co., Limited | 422,500 | 0 | 422,500 | 0 | SCHEDULE 13G, 2026-08-10 |
| Yingying Guo | 422,500 | 0 | 422,500 | 0 | SCHEDULE 13G, 2026-08-10 |
| Velociti Group Limited | 422,500 | 0 | 422,500 | 0 | SCHEDULE 13G, 2026-08-10 |
| Chunxin Xia | 422,500 | 0 | 422,500 | 0 | SCHEDULE 13G, 2026-08-10 |
| Fusen Advertising Design Limited | 422,500 | 0 | 422,500 | 0 | SCHEDULE 13G, 2026-08-10 |
| Hao Meng | 422,500 | 0 | 422,500 | 0 | SCHEDULE 13G, 2026-08-10 |
| Motovance Holdings Limited | 422,500 | 0 | 422,500 | 0 | SCHEDULE 13G, 2026-08-13 |
| Li Wang | 422,500 | 0 | 422,500 | 0 | SCHEDULE 13G, 2026-08-13 |
| Nexera Technology Company Limited | 390,000 | 0 | 390,000 | 0 | SCHEDULE 13G, 2026-08-10 |
| Jie Cao | 390,000 | 0 | 390,000 | 0 | SCHEDULE 13G, 2026-08-10 |
| Pinnacle International Holding Limited | 325,000 | 0 | 325,000 | 0 | SCHEDULE 13G, 2026-08-10 |
| Yajie Ma | 325,000 | 0 | 325,000 | 0 | SCHEDULE 13G, 2026-08-10 |
The latest filing identifies Park Ha Biological Technology Co., Ltd. by CUSIP G6925R128 and gives its principal executive office as 901 & 902-2, Building C, Phase 2, Wuxi International Life Science Innovati, Jiangsu Province (SCHEDULE 13G, 2026-08-13).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-08-10 | Corin Global Partners Holdings Limited | 9.8% | SCHEDULE 13G |
| 2026-08-10 | Peverel Summit Holdings Limited | 9.8% | SCHEDULE 13G |
| 2026-08-10 | Rove Trading Co., Limited | 9.8% | SCHEDULE 13G |
| 2026-08-10 | Velociti Group Limited | 9.8% | SCHEDULE 13G |
| 2026-08-10 | Nexera Technology Company Limited | 9.1% | SCHEDULE 13G |
| 2026-08-10 | Pinnacle International Holding Limited | 7.6% | SCHEDULE 13G |
| 2026-08-10 | Fusen Advertising Design Limited | 9.8% | SCHEDULE 13G |
| 2026-08-13 | Motovance Holdings Limited | 9.7% | SCHEDULE 13G |
Questions about who owns Park Ha Biological Technology Co., Ltd.
Who owns Park Ha Biological Technology Co., Ltd.?
On this page, 8 holders' latest ownership filings report 5% or more of Park Ha Biological Technology Co., Ltd.: Corin Global Partners Holdings Limited (9.8%, Schedule 13G, filed 2026-08-10), Peverel Summit Holdings Limited (9.8%, Schedule 13G, filed 2026-08-10), Rove Trading Co., Limited (9.8%, Schedule 13G, filed 2026-08-10), Velociti Group Limited (9.8%, Schedule 13G, filed 2026-08-10) and Fusen Advertising Design Limited (9.8%, Schedule 13G, filed 2026-08-10); 3 more are listed above.
Who are the largest shareholders of Park Ha Biological Technology Co., Ltd.?
By the share each holder's latest filing reports, the largest holders of Park Ha Biological Technology Co., Ltd. on this page are Corin Global Partners Holdings Limited (9.8%), Peverel Summit Holdings Limited (9.8%) and Rove Trading Co., Limited (9.8%).
When did Corin Global Partners Holdings Limited buy into Park Ha Biological Technology Co., Ltd.?
The filings give report dates, not purchase dates. The earliest filing from Corin Global Partners Holdings Limited on this page is the Schedule 13G, filed 2026-08-10, reporting 9.8%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 8 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Park Ha Biological Technology Co., Ltd.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| January 28, 2026 | IPO filing, Form 424B4 | $0.112 a share | IPO filings | Source |
| January 23, 2026 | IPO filing, Form F-1/A | — | IPO filings | Source |
| December 5, 2025 | IPO filing, Form F-1/A | — | IPO filings | Source |
| September 25, 2025 | IPO filing, Form F-1/A | — | IPO filings | Source |
| September 19, 2025 | IPO filing, Form F-1 | — | IPO filings | Source |
| December 27, 2024 | IPO filing, Form 424B4 | — | IPO filings | Source |
| December 20, 2024 | IPO filing, Form F-1/A | $4 to $6 a share | IPO filings | Source |
| December 6, 2024 | IPO filing, Form F-1/A | — | IPO filings | Source |
| November 6, 2024 | IPO filing, Form F-1/A | — | IPO filings | Source |
| October 9, 2024 | IPO filing, Form F-1/A | $4 to $6 a share | IPO filings | Source |
| September 18, 2024 | IPO filing, Form F-1/A | $5 to $7 a share | IPO filings | Source |
| August 26, 2024 | IPO filing, Form F-1 | $5 to $7 a share | IPO filings | Source |
Tools for this story
Each opens in a new tab, filled in for Park Ha Biological Technology Co., Ltd.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.